Company research
CervoMed Inc.
CIK 1053691Updated Nov 11, 2026
SecurityCRVO · NASDAQ · equity
Name history
Diffusion Pharmaceuticals Inc. · through Aug 14, 2023RestorGenex Corp · through Jan 14, 2016Stratus Media Group, Inc · through Mar 7, 2014FERIS INTERNATIONAL, INC. · through Jul 16, 2008TITAN MOTORCYCLE CO OF AMERICA INC · through Feb 22, 2008
CRVO price & chart
Loading TradingView…
NASDAQ:CRVO on TradingView ↗In the news
CervoMed to Participate in September Investor Conferences ↗
Recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
Show 5 more recent filings
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
SCHEDULE 13G/A - filed by RA CAPITAL MANAGEMENT, L.P. regarding CervoMed Inc.
SCHEDULE 13G/A - filed by CVI Investments, Inc. regarding CervoMed Inc.
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 30,610,778Source | 48,883,867Source | 25,992,471Source | 38,081,399Source | 53,190,649Source | 15,112,918Source | 38,577,488Source | 7,997,448Source | 22,879,018Source | 43,081,610Source | 9,972,521Source | 22,635,052Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 9,437,400Source | 7,743,667Source | 22,462,577Source | 8,320,713Source | 10,009,217Source | 7,941,751Source | 10,501,714Source | 6,369,172Source | 8,235,469Source | 8,999,496Source | 7,792,846Source | 10,113,706Source |
| Assets, CurrentUSD | 30,610,778Source | 48,809,930Source | 25,992,471Source | 38,081,399Source | 47,328,155Source | 15,112,918Source | 38,577,488Source | 7,965,522Source | 22,879,018Source | 43,081,610Source | 9,964,751Source | 22,635,052Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,685,972Source | 1,888,879Source | 733,718Source | 1,964,327Source | 2,236,436Source | 1,695,341Source | 1,703,747Source | 1,348,679Source | 1,267,005Source | 1,905,360Source | 1,256,501Source | — |
| Other Assets, NoncurrentUSD | — | 73,937Source | — | — | 56,234Source | — | — | 31,926Source | — | 0Source | 7,770Source | 0Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 4,599,314Source | 3,246,371Source | 3,032,174Source | 4,641,620Source | 3,213,736Source | 4,497,203Source | 3,943,001Source | 2,661,070Source | 4,656,117Source | 3,879,282Source | 2,595,747Source | 2,417,336Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 9,252Source | 8,253Source | 13,526Source | 9,252Source | 8,253Source | 9,258Source | 8,702Source | 6,170Source | 9,252Source | 8,702Source | 5,674Source | 2,040Source |
| Additional Paid in CapitalUSD | 115,606,949Source | 109,531,651Source | 135,180,330Source | 115,315,232Source | 109,260,391Source | 116,268,674Source | 110,230,080Source | 62,285,332Source | 115,905,684Source | 109,868,913Source | 61,811,889Source | 165,847,590Source |
| Retained Earnings (Accumulated Deficit)USD | -89,610,561Source | -64,025,570Source | -112,233,665Source | -81,883,922Source | -59,272,029Source | -105,662,009Source | -75,625,518Source | -56,955,124Source | -97,697,851Source | -70,731,484Source | -54,440,789Source | -145,596,539Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 5,824Source | 123,162Source | 106Source | -783Source | -19,702Source | -208Source | 21,223Source | — | 5,816Source | 56,197Source | — | -35,375Source |
| Stockholders' Equity Attributable to ParentUSD | 26,011,464Source | 45,637,496Source | 22,960,297Source | 33,439,779Source | 49,976,913Source | 10,615,715Source | 34,634,487Source | 5,336,378Source | 18,222,901Source | 39,202,328Source | 7,376,774Source | 20,217,716Source |
| Liabilities and EquityUSD | 30,610,778Source | 48,883,867Source | 25,992,471Source | 38,081,399Source | 53,190,649Source | 15,112,918Source | 38,577,488Source | 7,997,448Source | 22,879,018Source | 43,081,610Source | 9,972,521Source | 22,635,052Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | 4,656,117Source | — | — | — |
| Accounts Payable, CurrentUSD | 1,349,219Source | 1,082,435Source | 687,111Source | 1,845,609Source | 725,854Source | 2,272,497Source | 1,860,598Source | 679,739Source | 1,454,118Source | 1,511,440Source | 662,471Source | 1,127,782Source |
| Additional Financial Items | ||||||||||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 27,300,000Source | — | 24,900,000Source | 33,500,000Source | — | 12,900,000Source | — | — | 20,900,000Source | — | — | — |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | — |
| Preferred Stock, Value, Issued | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Deferred Revenue, Current | — | — | — | — | —Source | — | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 349,196Source | 361,167Source | 1,448,634Source | 1,405,722Source | 407,632Source | 928,052Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -426,993Source | -625,004Source | -1,827,238Source | 1,338,827Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 765,364Source | 349,158Source | -67,322Source | 848,969Source | 565,169Source | — |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -8,018,338Source | -3,894,359Source | -23,449,963Source | -16,530,827Source | -7,449,847Source | -14,969,114Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 7,710,820Source | 5,396,577Source | 18,097,249Source | -28,661,129Source | — | -12,235,738Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 13,800Source | 0Source | 4,588,687Source | 46,398,606Source | 11,149,114Source | 5,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -293,718Source | 1,502,218Source | -764,027Source | 1,206,650Source | 3,699,267Source | -27,199,852Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | 7,743,667Source | — | — | — | 10,501,714Source | — | 8,999,496Source | 7,792,846Source | 10,113,706Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 291,717Source | 271,215Source | 362,275Source | 497,015Source | 349,196Source | 361,167Source | 1,448,634Source | 1,405,722Source | 407,632Source | 928,052Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 27,300,000Source | — | 24,900,000Source | 33,500,000Source | 12,900,000Source | — | 20,900,000Source | — | — | — |
| Depreciation, NonproductionUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 2,326,326Source | 2,210,927Source | 2,356,779Source | 3,265,374Source | 2,975,105Source | 2,382,577Source | 10,484,315Source | 9,166,762Source | 6,519,268Source | 8,735,015Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | — | — | 0Source |
| Investment Income, InterestUSD | — | — | 318,787Source | 646,172Source | 104,897Source | 368,127Source | 147,387Source | 408,985Source | 1,336,837Source | 1,937,427Source | 219,430Source | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | — | — | — | -6,024Source | -34,974Source | — | 56,197Source | — | -35,375Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,726,639Source | -4,753,541Source | -6,571,656Source | -6,258,404Source | -7,964,158Source | -4,894,034Source | -26,966,367Source | -16,290,695Source | -2,171,873Source | -15,591,428Source |
| Nonoperating Income (Expense)USD | — | — | 317,560Source | 642,732Source | 106,895Source | 357,871Source | 146,366Source | 408,850Source | 1,328,510Source | 1,936,436Source | 5,641,022Source | — |
| Operating ExpensesUSD | — | — | 8,366,768Source | 7,336,024Source | 6,678,551Source | 8,373,999Source | 8,110,524Source | 7,220,375Source | 32,301,387Source | 27,965,105Source | 14,957,767Source | — |
| Operating Lease, ExpenseUSD | — | — | 16,200Source | 8,400Source | 21,600Source | 11,160Source | 21,600Source | 8,500Source | 57,112Source | 34,692Source | 34,000Source | 18,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -1,227Source | -3,440Source | 1,998Source | -10,256Source | -1,021Source | -135Source | -8,327Source | -991Source | 5,421,592Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | 46,398,606Source | 810,000Source | 0Source |
| Proceeds from Stock Options Exercised | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 322,569Source | 1,939,751Source | 0Source | 1,757,724Source | 0Source | 1,917,491Source | 4,006,510Source | 9,737,974Source | 7,144,872Source | — |
| Operating Income (Loss)USD | — | — | -8,044,199Source | -5,396,273Source | -6,678,551Source | -6,616,275Source | -8,110,524Source | -5,302,884Source | -28,294,877Source | -18,227,131Source | -7,812,895Source | -15,972,180Source |
| Other Nonoperating Income (Expense)USD | — | — | -1,227Source | -3,440Source | 1,998Source | -10,256Source | -1,021Source | -135Source | -8,327Source | -991Source | 5,421,592Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | -15,591,428Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | — | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,726,639Source | -4,753,541Source | -6,571,656Source | -6,258,404Source | -7,964,158Source | -4,894,034Source | -26,966,367Source | -16,290,695Source | -2,171,873Source | -15,591,428Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.84Source | -0.55Source | -0.64Source | -0.7Source | -0.86Source | -0.56Source | -2.98Source | -2.02Source | -0.82Source | -7.65Source |
| Earnings Per Share, DilutedUSD per share | — | — | — | -0.55Source | — | — | — | — | — | — | — | 2,038,891Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 9,252,719Source | 8,702,764Source | 10,244,516Source | 8,950,521Source | 9,258,319Source | 8,702,719Source | 9,041,760Source | 8,073,155Source | 2,661,416Source | — |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 2,326,326Source | 2,210,927Source | 2,356,779Source | 3,265,374Source | 2,975,105Source | 2,382,577Source | 10,484,315Source | 9,166,762Source | 6,519,268Source | 8,735,015Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 380,752Source |
| Investment Income, InterestUSD | — | — | 318,787Source | 646,172Source | 104,897Source | 368,127Source | 147,387Source | 408,985Source | 1,336,837Source | 1,937,427Source | 219,430Source | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Nonoperating Income (Expense)USD | — | — | 317,560Source | 642,732Source | 106,895Source | 357,871Source | 146,366Source | 408,850Source | 1,328,510Source | 1,936,436Source | 5,641,022Source | — |
| Operating ExpensesUSD | — | — | 8,366,768Source | 7,336,024Source | 6,678,551Source | 8,373,999Source | 8,110,524Source | 7,220,375Source | 32,301,387Source | 27,965,105Source | 14,957,767Source | — |
| Operating Lease, ExpenseUSD | — | — | 16,200Source | 8,400Source | 21,600Source | 11,160Source | 21,600Source | 8,500Source | 57,112Source | 34,692Source | 34,000Source | 18,000Source |
| Research and Development ExpenseUSD | — | — | 6,040,442Source | 5,125,097Source | 4,321,772Source | 5,108,625Source | 5,135,419Source | 4,837,798Source | 21,817,072Source | 18,798,343Source | 8,438,499Source | 7,237,165Source |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | —Source | — | — | — | — | — | — | — | — |